The Valley Desk

Clinical trial reportBritish journal of cancerPublished

Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name GSK, Merck & Co., Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
British journal of cancer
Published
Subject terms
Humans; Neoplasms; Antineoplastic Agents; Enzyme Inhibitors; Treatment Outcome; Maximum Tolerated Dose; Adult
PubMed ID
37237172
PubMed Central ID
PMC10338470
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal